ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

https://www.cyberknifemiami.com/earls-story-treating-kidney-cancer-at-cyberknife-miami-saving-both-kidneys/

https://m.youtube.com/watch?v=vWm5Qb7W8e4&feature=youtu.be&fbclid=IwAR3reI7VpRYh55D4MODOB91A1U-3NtjQzx9lX6RMP7e_BuI5M60ZHSMfhwo

Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors https://www.prnewswire.com/news-releases/accuray-appoints-healthcare-executive-and-physician-byron-c-scott-to-board-of-directors-301231609.html ...announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant experience as a physician executive with invaluable global expertise in healthcare analytics and technology.    ...

Lönne, klar, nach Covid kommt die in focus - wenn die Leute mal wieder merken, dass es Krebs ist, den man besiegen muss und keine Viren

Läuft die so unterm Radar?

https://www.royalmarsden.nhs.uk/your-care/treatments/radiotherapy/cyberknife

👍🍀

Danke Summer👍🌞

https://pub.webull.com/us/news-html/a3ac0d8a1cbf470884c00b77ce8b6083.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en&theme=1 Insider Trends: Insider Purchase Continues Accuray Positive Trend

https://www.pmlive.com/pmhub/healthcare_digital_communications/blue_latitude/white_papers_and_resources/the_heavy_toll_of_covid-19_on_cancer_patients?SQ_DESIGN_NAME=2

Accuray Reports Second Quarter Fiscal 2021 Financial Results https://www.prnewswire.com/news-releases/accuray-reports-second-quarter-fiscal-2021-financial-results-301216554.html Second Quarter Fiscal 2021 Summary Net revenue of $97.5 million including $21.3 million of system revenue in China Gross orders of $75.4 million, ending backlog of $596.2 million, an increase of 11 percent from December 31, 2019 GAAP operating income of $8.2 million and GAAP net income of $4.8 million compared to GAAP operating income of $3.6 million and GAAP net income of $10.7 million in the prior year second quarter Adjusted EBITDA grew to $13.5 million from $7.1 million in the prior year second quarter Received 510(k) FDA clearance for ClearRT Helical kVCT Imaging for the Radixact System ...

https://www-radiologyinfo-org.cdn.ampproject.org/c/s/www.radiologyinfo.org/en/amp/stereotactic.html

https://pubmed.ncbi.nlm.nih.gov/30847178/

🍀

😁🥳🏝️

Danke euch beiden